Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver
Open Access
- 1 September 2006
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 47 (9), 1950-1958
- https://doi.org/10.1194/jlr.m600224-jlr200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and GeranylgeraniolPublished by Elsevier BV ,2003
- YM‐53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodentsBritish Journal of Pharmacology, 2003
- Accelerated Degradation of HMG CoA Reductase Mediated by Binding of Insig-1 to Its Sterol-Sensing DomainMolecular Cell, 2003
- Role of Acyl-Coenzyme A:Cholesterol Acyltransferase-1 in the Control of Hepatic VLDL Secretion and LDL Receptor Expression in the Mouse and HamsterJournal of Biological Chemistry, 2000
- Regulated Intramembrane Proteolysis: A Control Mechanism Conserved from Bacteria to HumansCell, 2000
- Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDLJCI Insight, 1999
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.JCI Insight, 1993
- Regulation of the mevalonate pathwayNature, 1990
- Regulation of squalene synthetase activity in rat liver: Elevation by cholestyramine, but no diurnal variationBiochemical and Biophysical Research Communications, 1986
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983